Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Star Scientific, Inc.

Market Cap 153K 135K 124K 116K 218K 14.53M 221K 1.49M 577K 7.13M 576K 563K 24.78M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.58M 16.2M 15.16M 28.41M 1.9B 28.89M 194M 75.29M 930M 75.12M 73.5M 3.23B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.39%-1.51%+43.46%+140.94% 983B
+2.75%+0.85%+56.74%+43.33% 557B
+2.07%+5.47%+27.69%+72.63% 406B
+1.53%-1.93%+23.33%+16.35% 314B
+2.26%+2.30%+30.42%+18.98% 273B
+2.61%+3.11%+29.81%+36.09% 272B
+2.60%+9.79%-31.71%-43.45% 203B
+0.86%-0.08%+27.57%+53.04% 186B
+0.81%-1.13%+18.46%+62.37% 155B
Average +1.87%-0.92%+25.09%+44.48% 372.26B
Weighted average by Cap. +1.68%-2.22%+33.09%+66.56%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.84M -31.18M -29.19M -54.69M -3.65B -55.61M -374M -145M -1.79B -145M -141M -6.22B -6.84M -6.01M -5.54M -5.19M -9.72M -648M -9.88M -66.53M -25.75M -318M -25.7M -25.14M -1.11B
Net Debt -45K -39.53K -36.43K -34.1K -63.89K -4.26M -64.97K -437K -169K -2.09M -169K -165K -7.27M 19.86M 17.44M 16.07M 15.05M 28.19M 1.88B 28.67M 193M 74.71M 923M 74.54M 72.94M 3.21B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!